Related Experiment Video
Updated: Aug 10, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Specific positive and negative effects of FLIP on cell survival in human prostate cancer
Keiji Shimada1, Mitsutoshi Nakamura, Syuichi Matsuyoshi
1Department of Pathology, Nara Medical University School of Medicine, Nara, 634-8521, Japan.
Abstract:
We demonstrate here for the first time novel positive and negative effects of the FLICE-like inhibitory protein (FLIP) on human prostate cancer cell survival. A proteaosome inhibitor, MG132, mediated cell cycle arrest at G2/M and apoptosis through p38 activation. Interestingly, FLIP was stabilized by MG132 and interacted with Raf-1, resulting in enhancement of p38 signals and cytotoxicity. In contrast, overexpression of FLIP inhibited ubiquitylation and proteasomal degradation of beta-catenin, resulting in increase of the target gene cyclin D1, colony formation and invasive activity. Immunohistochemical analysis and in vitro experiments in primary culture showed FLIP to be overexpressed, statistically associated with expression of beta-catenin/cyclin D1 in metastatic cells, the FLIP/beta-catenin/cyclin D1 signals contributing to colony formation and invasion, which were canceled by FLIP knock down. In contrast, MG132-induced cytotoxicity including apoptosis was strongly inhibited by reduction of FLIP. Taken together, the results indicate that FLIP plays an important role in development of metastatic prostate cancer by inhibiting proteasomal degradation of beta-catenin, whereas it is mainly involved in proteasome inhibitior-mediated cell cycle arrest and apoptosis through activating the Raf-1/p38 pathway. Furthermore, proteasome inhibitors may be effective drugs for advanced prostate cancers overexpressing FLIP.
Insights
FLICE-like inhibitory protein (FLIP) has dual roles in prostate cancer. It promotes metastasis by stabilizing beta-catenin but enhances proteasome inhibitor-induced apoptosis via the Raf-1/p38 pathway.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- FLICE-like inhibitory protein (FLIP) role in cancer is complex.
- Prostate cancer progression involves cell survival and invasion.
- Proteasome inhibitors are investigated for cancer therapy.
Purpose of the Study:
- To elucidate the multifaceted roles of FLIP in human prostate cancer.
- To investigate FLIP's interaction with proteasome inhibitors and its impact on cell signaling.
- To determine FLIP's contribution to prostate cancer metastasis and survival.
Main Methods:
- Cell culture and treatment with proteasome inhibitor MG132.
- Western blotting to assess protein levels and interactions (FLIP, beta-catenin, cyclin D1, Raf-1, p38).
- Immunohistochemistry and in vitro assays for colony formation and invasion.
- FLIP knockdown experiments.
Main Results:
- MG132 induced G2/M arrest and apoptosis via p38 activation.
- MG132 stabilized FLIP, enhancing Raf-1/p38 signaling and cytotoxicity.
- Overexpressed FLIP inhibited beta-catenin ubiquitylation, increasing cyclin D1, colony formation, and invasion.
- FLIP overexpression correlated with beta-catenin/cyclin D1 in metastatic cells.
- FLIP knockdown reversed pro-metastatic effects.
- FLIP reduction inhibited MG132-induced apoptosis.
Conclusions:
- FLIP promotes prostate cancer metastasis by inhibiting beta-catenin proteasomal degradation.
- FLIP mediates proteasome inhibitor-induced apoptosis through the Raf-1/p38 pathway.
- FLIP is a potential therapeutic target, and proteasome inhibitors may benefit advanced prostate cancers overexpressing FLIP.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Negative Regulator Molecules
Replicative Cell Senescence
Abnormal Proliferation

